JOHNSON JOHNSON THAILAND PROVIDES HOLISTIC DIABETES CARE SOLUTIONS WITH NEW IN-STORE PROGRAM AT FASCINO TO MARK WORLD DIABETES DAY

Food and Healthcare Press Releases Wednesday December 6, 2017 13:55
Bangkok--6 Dec--Johnson & Johnson

Johnson & Johnson (Thailand) Limited marked World Diabetes Day this month by launching a new in-store holistic diabetes care program at FASCINO, one of the leading pharmacy chains operating in Thailand. The program aims to provide access to diabetes management information and solutions at a specialized location within each of the 43 outlets of the FASCINO network across the country.

In Thailand, around 6.5 Million people have Diabetes and the prevalence is likely to increase by 10% every year. The initiative covers all aspects of self-care through a unique in-store set-up including oral health, skin care, and foot care that play an important role in daily management of the condition in addition to blood sugar monitoring and taking medicines consistently.

Mr. Neeraj Goyal, Marketing Director of Johnson & Johnson (Thailand) Limited said "Johnson & Johnson is committed towards health and wellness of consumer & patient in Thailand and it is continuously addressing the well-being of people in Thailand. Diabetes was identified as one of the disease areas where more support could be provided at a retail level to consumers and patients."

"Johnson & Johnson has a strong legacy and expertise in diabetes care and FASCINO is one of the most reputable pharmacies in Thailand with a widespread network. Through this initiative we shall be reaching out to a large number of people across the country to educate them on the disease state and also provide solutions to enable holistic management of their health and wellness associated with diabetes outside of medical and hospital care. These include our consumer range of products from Aveeno for skincare to Listerine for oral hygiene as well as blood glucose monitoring meters and solutions for pain management, provided through a unique in-store display for easy access and certain long term measures like smoking cessation."

Pharmacist Chaisen Pisanwaler, Managing Director, Profascino Co., Ltd said "the community pharmacy can play a key role in helping to improve the quality of life of those impacted by diabetes. We are proud to have introduced this one-of-a kind initiative at a retail level that addresses an important healthcare need for Thai people through a well-selected range of products and their related educational materials for holistic diabetes care.The initiative has been well-received by consumers across FASCINO stores and we are looking forward to working together with Johnson & Johnson on other such programs in the near future".

About Johnson & Johnson

Caring for the world one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 132,500 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

*From the statistic, the number and rate of people affected diabetes (E10-E14) per 100,000 people (including all diagnostics) in year 2007 - 2014

Latest Press Release

Walgreens Boots Alliance and Microsoft establish strategic partnership to transform health care delivery

- Companies aim to improve health outcomes and lower overall costs with enhanced digital and retail experiences and an R&D commitment to build health care solutions through seven-year agreement Walgreens Boots Alliance Inc. (WBA) and Microsoft Corp....

Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems

Ascensia Diabetes Care today announced it has entered into a global alliance with Zhejiang POCTech, Co., Ltd (POCTech), a developer and manufacturer of continuous glucose monitoring (CGM) systems. (Logo:...

MGI Announces Milestone of 1,000 Sequencers Installed and Opens Early Access Program for Groundbreaking Ultra-High-Throughput Sequencer, MGISEQ-T7

MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI's...

Gift of Life Donor Program is U.S. Leader in Saving Lives

For the 11th consecutive year, Gift of Life Donor Program is the nation's leading organ procurement organization (OPO), coordinating the most life-saving organs for transplant among all 58 U.S. OPOs. Gift of Life broke two national records in 2018,...

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

Licensing rights are worldwide excluding US, Canada, Japan and South AmericaHelsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, today...

Related Topics